Discover the World’s Fastest Business Insights
Get real-time alerts on funding rounds, executive hires, acquisitions, and more— plus verified contact details and AI-powered outreach to connect faster.
Sign up now to unlock exclusive data and opportunities.
Anocca Raises $47M In A Series B Financing To Advance Its Industrialised Approach To Tcr-T Cellular Immunotherapy
Anocca Raises $47M In A Series B Financing To Advance Its Industrialised Approach To Tcr-T Cellular Immunotherapy
Company Info
Company news
Tue, 13 Feb 2024 08:00:00 GMT
Anocca Appoints Martin Welschof to Board of Directors - GlobeNewswire
Mon, 09 Sep 2024 07:00:00 GMT
Anocca Presents Data at ESMO Congress on Preclinical Development of its TCR-T Cell Therapies for Cancer - Yahoo Finance
Thu, 22 Jul 2021 07:00:00 GMT
Anocca Raises $47m in a Series B Financing to Advance Its Industrialised Approach to TCR-T Cellular Immunotherapy - Business Wire
Thu, 30 May 2024 07:00:00 GMT
Shinobi and Anocca to advance cancer killing iPS-T cell therapies - BioProcess Insider
Thu, 30 May 2024 07:00:00 GMT
Anocca AB and Shinobi Therapeutics Announce Strategic - GlobeNewswire
Mon, 12 Jun 2023 07:00:00 GMT
Significant capital injections into Vicore Pharma and Anocca - BioStock - Connecting Innovation and Capital
Wed, 31 May 2023 07:00:00 GMT
Anocca raises SEK 400 million for large-scale development of cancer cell therapies - Yahoo Finance
Tue, 26 Nov 2024 08:00:00 GMT
Anocca Announces Submission of Clinical Trial Application - GlobeNewswire
Thu, 14 Mar 2024 07:00:00 GMT
Anocca AB Licenses Gene Editing Technology from EmendoBio Inc. - GlobeNewswire
Never Miss an Opportunity: Your #1 Sales Intelligence Tool
Get lightning-fast updates on funding rounds, executive hires, contract awards, and more—powered by AI-driven insights to help you connect with the right prospects first.